Participants with the BioInnovate Ireland bio-medical start-up accelerator will now have the support of Ernst & Young (EY) to provide financial advice in terms of fundraising, taxation, valuation and business modelling.
With applications now being taken for the 2016 medical device innovation collaboration, the BioInnovate Ireland medical device innovation training programme is based in NUI Galway and is modelled on the Stanford Biodesign programme.
With the addition of EY as a partner, the programme will now also be able to provide access to its large entrepreneurial network through the EY Entrepreneur of the Year programme to enable the BioInnovate fellows to share their experiences and discuss solutions to the challenges facing entrepreneurial businesses in the medical technology sector.
Programme director for BioInnovate Ireland, Dr Mark Bruzzi, said of the new partnership with EY: “BioInnovate offers a unique opportunity for innovators to work together in teams to identify and develop new innovations to make an impact on healthcare and the medical device industry. By partnering with EY, BioInnovate aims to build on the supports to enable early stage enterprise in the medical technology sector”.
Aidan Meagher of EY added the professional services firm’s praise for the programme: “Technological breakthroughs are revolutionising the way healthcare is being delivered and, as the health marketplace rapidly changes and evolves to meet new demands, we are excited to partner with BioInnovate to support the next wave of entrepreneurs on the cutting edge of medical device innovation.”